Skip to main content
Search
Search
    Quick Search anywhere
    Quick search in Citations
Advanced Search
Skip main navigationClose Drawer MenuOpen Drawer Menu
Previous article
Next article
Original Communication

Anti-hyperglycemic effects of propolis or metformin in type 2 diabetes mellitus

A randomized controlled trial

Published Online:August 15, 2022https://doi.org/10.1024/0300-9831/a000760

Abstract

Abstract:Background: The aim of this study was to evaluate the effect of propolis or metformin versus placebo on glycemic control in pharmacological treatment-naïve patients with type 2 diabetes mellitus (T2DM). Methods: A double-blind, randomized, placebo-controlled in parallel groups clinical trial was performed in 36 pharmacological treatment-naïve patients with T2DM. They received propolis (300 mg), metformin (850 mg), or placebo twice daily before breakfast and dinner for 12 weeks. At the beginning and end of the study, fasting plasma glucose (FPG), 2-h postload glucose (2-h PG) during a 75-g oral glucose tolerance test, glycated hemoglobin A1c (A1C) and a metabolic profile were measured. Areas under the curve (AUC) of glucose and insulin, total insulin secretion (insulinogenic index), the first phase of insulin secretion (Stumvoll index), and insulin sensitivity (Matsuda index) were calculated. Statistical analyses: Kruskal-Wallis, Mann-Whitney U and Wilcoxon tests. Results: The propolis and metformin groups exhibited significant reductions in FPG (p=0.009 and p=0.001, respectively), 2-h PG (p=0.034 and p=0.001, respectively) levels, AUC of insulin, Stumvoll index, and an increment in the Matsuda index. The comparison of the changes from baseline to the end showed significant differences between placebo and propolis in FPG (p=0.004) and A1C (p=0.049) levels, while between placebo and metformin were in FPG (p=0.002), 2-h PG (p=0.004) and A1C (p=0.007) levels. Conclusions: The administration of propolis and metformin compared to placebo reduced FPG and A1C levels; in addition, metformin decreased 2-h PG, AUC of glucose and insulin, high-density lipoprotein cholesterol, and increased the insulin sensitivity.

References

  • 1 Raja R, Kumar V, Khan MA, Sayeed KA, Maroof SZ, Rizwanet A. Knowledge, attitude, and practices of complementary and alternative medication usage in patients of type II diabetes mellitus. Cureus. 2019;11(8):1–12. First citation in articleGoogle Scholar

  • 2 Bankova V, Popova M, Trusheva B. Propolis volatile compounds. Chemical diversity and biological activity: a review. Chem Cent J. 2014;8(28):1–8. First citation in articleMedline, Google Scholar

  • 3 El-Sharkawy H, Anees M, Van Dyke T. Propolis improves periodontal status and glycemic control in patients with type 2 Diabetes Mellitus and chronic periodontitis: a randomized clinical trial. J Periodontol. 2016;87(12):1418–26. First citation in articleCrossref Medline, Google Scholar

  • 4 Samadi N, Mozaffari-Khosravi H, Rahmanian M, Askarishahi M. Effects of bee propolis supplementation on glycemic control, lipid profile and insulin resistance indices in patients with type 2 diabetes: a randomized, double-blind clinical trial. J Integr Med. 2017;15(2):124–34. First citation in articleCrossref Medline, Google Scholar

  • 5 Afsharpour F, Javadi M, Hashemipour S, Koushan Y, Khadem H. Propolis supplementation improves glycemic and antioxidant status in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. Complement Ther Med. 2019;43(4):283–8. First citation in articleCrossref Medline, Google Scholar

  • 6 Zakerkish M, Jenabi M, Zaeemzadeh N, Hemmati AA, Neisi N. The effect of iranian propolis on glucose metabolism, lipid profile, insulin resistance, renal function and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind clinical trial. Sci Rep. 2019;9(1):1–11. First citation in articleCrossref Medline, Google Scholar

  • 7 Fukuda T, Fukui M, Tanaka M, Senmaru T, Iwase H, Yamazaki M, et al. Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study. Biomed Rep. 2015;3(3):355–60. First citation in articleCrossref Medline, Google Scholar

  • 8 Zhao L, Pu L, Wei J, Li J, Wu J, Xin Z, et al. Brazilian green propolis improves antioxidant function in patients with type 2 diabetes mellitus. Int J Environ Res Public Health. 2016;13(5):498. First citation in articleCrossref Medline, Google Scholar

  • 9 Gao W, Pu L, Wei J, Yao Z, Wang Y, Shi T, et al. Serum antioxidant parameters are significantly increased in patients with type 2 diabetes mellitus after consumption of Chinese propolis: a randomized controlled trial based on fasting serum glucose level. Diabetes Ther. 2018;9(1):101–11. First citation in articleCrossref Medline, Google Scholar

  • 10 American Diabetes Association. Standards of medical care in diabetes 2021. Diabetes Care. 2021;44:S15–S124. First citation in articleCrossref Medline, Google Scholar

  • 11 Apostolova N, Iannantuoni F, Gruevska A, Muntane J, Rocha Victor VM. Mechanisms of action of metformin in type 2 diabetes. Effects on mitochondria and leukocyte-endothelium interactions. Redox Biol. 2020;2020(34):1–12. First citation in articleGoogle Scholar

  • 12 Gökçay CA, Şahin M. Glucose lowering treatment modalities of type 2 diabetes mellitus. Adv Exp Med Biol. 2021;1307:7–27. First citation in articleCrossref Medline, Google Scholar

  • 13 Stumvoll M. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Epidemiol Serv Psychosoc Res. 2000;23(3):295–301. First citation in articleGoogle Scholar

  • 14 Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic glucose clamp. Diabetes Care. 1999;22(9):1462–70. First citation in articleCrossref Medline, Google Scholar

  • 15 Jones K, Arslanian S, Peterokova V, Park J-S. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2002;25(1):89–94. First citation in articleCrossref Medline, Google Scholar

  • 16 Evidence based medicine. The mechanism of metformin’s (glucophage) lowering fasting glucose levels and hepatogluconeogenesis. Available from: www.ebmconsult.com/articles/metformin-hypoglycemia-mechanism-diabetes First citation in articleGoogle Scholar

  • 17 Laiteerapong N, Ham SA, Gao Y, Moffet HH, Liu JY, Huang ES, et al. The legacy effect in type 2 diabetes: impact of early glycemic control on future complications (the diabetes & aging study). Diabetes Care. 2019;42(3):416–26. First citation in articleCrossref Medline, Google Scholar

  • 18 Shamah-Levy T, Cuevas-Nasu L, Romero-Martínez M, et al. Encuesta Nacional de Salud y Nutrición 2018–19. Resultados nacionales. Instituto Nacional de Salud Pública. México; 2020. First citation in articleGoogle Scholar

  • 19 Karimian J, Hadi A, Pourmasoumi M, Najafgholizadeh A, Ghavami A. The efficacy of propolis on markers of glycemic control in adults with type 2 diabetes mellitus: a systematic review and meta-analysis. Phytother Res. 2019;33(6):1616–26. First citation in articleCrossref Medline, Google Scholar

  • 20 Kang LJ, Lee HB, Bae HJ, Lee SG. Antidiabetic effect of propolis: reduction of expression of glucose-6-phosphatase through inhibition of Y279 and Y216 autophosphorylation of GSK-3α/β in HepG2 cells. Phyther Res. 2010;24(10):1554–61. First citation in articleCrossref Medline, Google Scholar

  • 21 Ueda M, Hayashibara K, Ashida H. Propolis extract promotes translocation of glucose transporter 4 and glucose uptake through both PI3K- and AMPK-dependent pathways in skeletal muscle. BioFactors. 2013;39(4):457–66. First citation in articleCrossref Medline, Google Scholar

  • 22 Al-Hariri M. Glycemic control and anti-osteopathic effect of propolis in diabetic rats. Diabetes Metab Syndr Obes Targets Ther. 2011;377–84. First citation in articleCrossref Medline, Google Scholar

  • 23 Mujica V, Orrego R, Pérez J, Romero P, Ovalle P, Zúñiga-Hernández J, Arredondo M, Leiva E. The Role of Propolis in Oxidative Stress and Lipid Metabolism: A Randomized Controlled Trial. Evid Based Complement Alternat Med. 2017;2017:4272940. First citation in articleCrossref Medline, Google Scholar

  • 24 Zheng Y, Wu Y, Tao L, Chen X, Jones TJ, Wang K, Hu F. Chinese propolis prevents obesity and metabolism syndromes induced by a high fat diet and accompanied by an altered gut microbiota structure in mice. Nutrients. 2020;12(4):959. First citation in articleCrossref Medline, Google Scholar

  • 25 Moustafa HAM, El Wakeel LM, Halawa MR, Sabri NA, El-Bahy AZ, Singap AN. Effect of Nigella Sativa oil versus metformin on glycemic control and biochemical parameters of newly diagnosed type 2 diabetes mellitus patients. Endocrine. 2019;65(2):286–94. First citation in articleCrossref Medline, Google Scholar

  • 26 Kitamura H, Effects of propolis extract and propolis-derived compounds on obesity and diabetes: knowledge from cellular and animal models. Molecules. 2019;24(23):1–53. First citation in articleCrossref, Google Scholar

  • 27 Lim S, Han KA, Yu J, Chamnan P, Kim ES, Yoon KH, et al. Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study). Diabetes Obes Metab. 2017;19(1):87–97. First citation in articleCrossref Medline, Google Scholar

  • 28 Chen X-m, Zhang W-q, Tian Y, Wang L-f, Ch-ch Chen, Ch-m Qiu. Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes. Cardiovasc Diabetol. 2018;17(1):1–8. First citation in articleCrossref Medline, Google Scholar

  • 29 Lin SH, Cheng PC, Te TuS, Hsu SR, Cheng YC, Liu YH. Effect of metformin monotherapy on serum lipid profile in statin-naïve individuals with newly diagnosed type 2 diabetes mellitus: A cohort study. PeerJ. 2018;2018(4):1–10. First citation in articleGoogle Scholar

  • 30 Von Eckardstein A, Sibler RA. Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2. Curr Opin Lipidol. 2011;22:26–32. First citation in articleCrossref Medline, Google Scholar

  • 31 Cai W, Xu J, Li G, Liu T, Guo X, Wang H, et al. Ethanol extract of propolis prevents high-fat diet-induced insulin resistance and obesity in association with modulation of gut microbiota in mice. Food Res Int. 2020;130:1–14. First citation in articleCrossref, Google Scholar

  • 32 Gutch M, Kumar S, Razi SM, Gupta KK, Gupta A. Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab. 2015;19(1):160–4. First citation in articleCrossref Medline, Google Scholar

  • 33 Brutsaert EF, Shitole S, Biggs ML, Mukamal KJ, deBoer IH, Thacker EL, et al. Relations of postload and fasting glucose with incident cardiovascular disease and mortality late in life: The cardiovascular health study. J Gerontol A Biol Sci Med Sci. 2016;71(3):370–7. First citation in articleCrossref Medline, Google Scholar

  • 34 Do Vale Moreira NC, Ceriello A, Basit A, et al. Race/ethnicity and challenges for optimal insulin therapy. Diabetes Res Clin Pr. 2021;175:1–11. First citation in articleCrossref, Google Scholar